Elise Chang Hillmann, MD PA | |
654 W Indiantown Rd, Ste 103, Jupiter, FL 33458-7546 | |
(561) 745-8602 | |
(561) 745-8673 |
Full Name | Elise Chang Hillmann |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 39 Years |
Location | 654 W Indiantown Rd, Jupiter, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386649853 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ND0900X | Dermatology - Dermatopathology | ME64945 (Florida) | Primary |
Entity Name | Elise Chang Hillmann Md Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154616811 PECOS PAC ID: 4981874930 Enrollment ID: O20131009000435 |
News Archive
3M Health Care today announced the launch of 3M™ Tegaderm™ I.V. Advanced Securement Dressing for patients, a comprehensive solution with transparent, breathable film, a stabilization border and new, comfort adhesive technology. The new dressing is perceived by clinicians to reduce catheter manipulation and resist staining which could lead to less frequent dressing changes, and may provide a cost savings option for hospitals.
Raloxifene is a U.S. Food and Drug Administration (FDA)-approved treatment for decreasing fracture risk in osteoporosis.
Nineteen McGill University researchers exploring issues from biomaterials to global climate change to advanced mathematics are among the 181 newly appointed or renewed Canada Research Chairs announced September 23 by the Honourable Gary Goodyear, Minister of State (Science and Technology.)
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Elise Chang Hillmann, MD PA 654 W Indiantown Rd, Ste 103, Jupiter, FL 33458-7546 Ph: (561) 745-8602 | Elise Chang Hillmann, MD PA 654 W Indiantown Rd, Ste 103, Jupiter, FL 33458-7546 Ph: (561) 745-8602 |
News Archive
3M Health Care today announced the launch of 3M™ Tegaderm™ I.V. Advanced Securement Dressing for patients, a comprehensive solution with transparent, breathable film, a stabilization border and new, comfort adhesive technology. The new dressing is perceived by clinicians to reduce catheter manipulation and resist staining which could lead to less frequent dressing changes, and may provide a cost savings option for hospitals.
Raloxifene is a U.S. Food and Drug Administration (FDA)-approved treatment for decreasing fracture risk in osteoporosis.
Nineteen McGill University researchers exploring issues from biomaterials to global climate change to advanced mathematics are among the 181 newly appointed or renewed Canada Research Chairs announced September 23 by the Honourable Gary Goodyear, Minister of State (Science and Technology.)
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
› Verified 6 days ago
Richard Mayron, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1095 Military Trail, # 2700, Jupiter, FL 33468 Phone: 561-632-2794 | |
Thomas H. Cahn, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 224 Chimney Corner Ln Apt 3002, Jupiter, FL 33458 Phone: 561-820-0155 Fax: 561-691-3281 | |
Peter Andrew Vitulli Jr., DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4600 Military Trl, Suite 107, Jupiter, FL 33458 Phone: 561-427-2000 Fax: 561-776-2565 | |
Ricardo Mejia, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2101 S Us Highway 1, Jupiter, FL 33477 Phone: 561-748-0510 Fax: 561-748-0598 | |
John Paul Kowalczyk, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4495 Military Trl, Suite 204, Jupiter, FL 33458 Phone: 561-296-1122 Fax: 561-296-5566 | |
Noah Kawika Weisberg, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4601 Military Trl, Suite 203, Jupiter, FL 33458 Phone: 561-775-6011 Fax: 561-775-6044 |